Stay updated on Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial page.

Latest updates to the Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial page
- Check4 days agoChange DetectedAdded a citation: Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma (N Engl J Med, 2021). Deleted the Erratum entry for that publication.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check33 days agoChange DetectedA NEJM publication citation was added and the same citation was removed from the Publications section.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-status notice about government funding lapses and the older Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check61 days agoChange DetectedA government funding status notice was added to the page. The page revision was updated to v3.4.1, replacing v3.4.0.SummaryDifference0.2%

Stay in the know with updates to Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial page.